发明名称 |
Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride for use in the treatment of muscular dystrophy |
摘要 |
The present invention relates to a method for treating muscular dystrophy which comprises administering diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride or other pharmaceutically acceptable salts and/or solvates thereof to a patient in need of such a treatment.;The invention further relates to a method for treating muscular dystrophy which comprises administering diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride or other pharmaceutically acceptable salts and/or solvates thereof in combination with one or more additional anti-inflammatory active agents to a patient in need of such a treatment. |
申请公布号 |
US9421184(B2) |
申请公布日期 |
2016.08.23 |
申请号 |
US201414444959 |
申请日期 |
2014.07.28 |
申请人 |
ITALFARMACO S.P.A. |
发明人 |
Saccone Valentina;Consalvi Silvia;Puri Pier Lorenzo;Mascagni Paolo |
分类号 |
A61K31/325;A61K9/00;A61K31/167;A61K31/573;A61K45/06;A61K31/58 |
主分类号 |
A61K31/325 |
代理机构 |
Perkins Coie LLP |
代理人 |
Perkins Coie LLP ;Kung Viola T. |
主权项 |
1. A method for treating muscular dystrophy in a patient, comprising administering to a patient in need thereof an active agent consisting of diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphthalen-2-yl-methyl]-ammonium chloride, or the pharmaceutically acceptable salts and/or solvates thereof. |
地址 |
Milan IT |